ClinicalTrials.govpublic full text
Exploring the Treatment Duration of PD-1 Neoadjuvant Therapy in Stage II-III dMMR Rectal Cancer
immune-related adverse event, neoadjuvant therapy, dmmr colorectal cancer
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 383566
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.